SeeThruEquity Upgrades RXMD Price Target to $0.35 per Share BY GlobeNewswire — 9:27 AM ET 03/09/2018 MIAMI, March 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( RXMD Loading... Loading... ) , a healthcare services and technology company, announces upgraded price target to $0.35 per share from SeeThruEquity.
SeeThruEquity, a premier small and microcap research firm, released an updated analyst report today upgrading Progressive Care’s price target to $0.35 per share. The upgrade is based on recent news of the Company’s intent to acquire a pharmacy in Palm Beach County as well as increased sales, new product and technology development projects, and the acceptance Bitcoin. SeeThruEquity’s report issues analysis on the Company’s current business and releases new sales targets which provide the basis for the upgraded price target for RXMD.
“We are excited to see that SeeThruEquity has initiated updated coverage of the Company,” stated S. Parikh Mars, CEO. "We believe that we are executing on our objectives as we take the Progressive Care ( RXMD Loading... Loading... ) to the next level. We are humbled by the response to our story and remain focused on delivering results to our patients and shareholders alike.”
Get connected and stay in touch with us on social media:
News 
Market Data 
Discover 
AI
